Fulgent Genetics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $84,069 | $81,803 | $73,463 | $76,214 |
Gross Profit | 35,512 | 34,435 | 28,346 | 31,849 |
EBITDA | -77 | -15,448 | -5,790 | -9,943 |
EBIT | -6,115 | -21,502 | -11,709 | -16,135 |
Net Income | -6,608 | -18,957 | -11,530 | -5,888 |
Net Change In Cash | 84,069 | 81,803 | 73,463 | 76,214 |
Free Cash Flow | 5,057 | -36,997 | -9,149 | 21,240 |
Cash | 117,641 | 87,880 | 67,281 | 55,144 |
Basic Shares | 30,749 | 30,832 | 30,832 | 30,652 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $283,470 | $289,213 | $618,968 | $992,584 |
Gross Profit | 107,215 | 104,456 | 366,901 | 777,051 |
EBITDA | -48,990 | -147,454 | 217,700 | 106,047 |
EBIT | -73,918 | -173,597 | 185,038 | 104,339 |
Net Income | -42,708 | -167,825 | 143,403 | 104,339 |
Net Change In Cash | 283,470 | 289,213 | 618,968 | 992,584 |
Cost of Revenue | 77,434 | |||
Free Cash Flow | -19,255 | 4,796 | 234,745 | 514,733 |
Cash | 55,144 | 97,473 | 79,506 | 164,894 |
Basic Shares | 30,235 | 29,784 | 30,964 | 30,976 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.14 |
2025-06-30 | -$0.62 |
2025-03-31 | $0.04 |
